Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tencent Music

13.32
-0.1600-1.19%
Post-market: 13.320.0003+0.00%19:52 EST
Volume:8.03M
Turnover:107.29M
Market Cap:22.86B
PE:24.46
High:13.79
Open:13.64
Low:13.06
Close:13.48
Loading ...

Are Tencent Music Entertainment Group's (NYSE:TME) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.
·
30 Dec 2024

Top Calls on Wall Street: Estee Lauder, ServiceTitan, Tencent Music and More

Tiger Newspress
·
27 Dec 2024

86Research Upgrades Tencent Music Entertainment to Buy, Price Target is $14

MT Newswires Live
·
27 Dec 2024

Tencent Music upgraded to Buy from Hold at 86 Research

TIPRANKS
·
27 Dec 2024

Press Release: IO Biotech secures up to EUR57.5 million in debt financing from the European Investment Bank

Dow Jones
·
20 Dec 2024

Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

GlobeNewswire
·
19 Dec 2024

TME vs. RELX: Which Stock Is the Better Value Option?

Zacks
·
19 Dec 2024

Asian Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading, End Week Lower

MT Newswires Live
·
13 Dec 2024

Press Release: TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.

Dow Jones
·
12 Dec 2024

Stock Track | Tencent Music Soars 10.04% as China's Looser Monetary Policy Boosts Growth Optimism

Stock Track
·
09 Dec 2024

China ETFs and ADRs Rally; Fangdd Network Soars 114%; YINN Rises 24%

Reuters
·
09 Dec 2024

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

GlobeNewswire
·
09 Dec 2024

Stock Track | Tencent Music Soars 5% in Pre-Market as China Signals Looser Monetary Policy to Boost Growth

Stock Track
·
09 Dec 2024

Stock Track | Tencent Music Soars Nearly 6% as China Signals Looser Monetary Policy to Boost Growth

Stock Track
·
09 Dec 2024

BRIEF-TME Pharma Says Net Proceeds To Extend Financial Visibility Into June 2025

Reuters
·
04 Dec 2024

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

GlobeNewswire
·
03 Dec 2024